Gay, H. A., Wu, N., Luo, J., Kuker, R., Heath, E. I., Dandapani, S. V., Myint, Z., Courtney, K. D., D'souza, A., Mayer, L. R., Welch, C., Johanns, T. M., Pelosof, L. C., Gore, S., Lukinova, N., Michalski, J. M., Mar, N. (2025). A phase l and randomized phase ll trial of radium-223 dichloride, peposertib, and avelumab in advanced metastatic castrate-resistant prostate cancer (mCRPC): Phase l results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5069